Welcome to our dedicated page for Enfusion news (Ticker: ENFN), a resource for investors and traders seeking the latest updates and insights on Enfusion stock.
Enfusion, Inc. (ENFN) appears in financial news as a provider of software-as-a-service solutions for investment managers, hedge funds, and asset managers, and as the subject of a completed acquisition by Clearwater Analytics Holdings, Inc. News coverage highlights Enfusion’s role in the investment management technology landscape and its integration into Clearwater’s broader platform.
Readers of this ENFN news page can expect articles that discuss Enfusion’s corporate transactions, including the definitive merger agreement announced with Clearwater and the subsequent completion of that acquisition in a transaction valued at approximately $1.5 billion. News items also describe the strategic rationale for combining Enfusion’s front-office capabilities with Clearwater’s middle- and back-office solutions to create a unified, cloud-native front-to-back investment management platform.
Historical news about Enfusion includes financial results such as fourth quarter and full year 2024 performance, where the company reported revenues, margins, and key metrics like Annual Recurring Revenue and Net Dollar Retention Rate. Such releases provide insight into Enfusion’s business model as a SaaS platform serving investment managers with platform subscriptions and managed services.
Other news references Enfusion’s positioning in the hedge fund and asset management sectors and its global footprint, as well as its description as an investment management SaaS platform that unites front-, middle-, and back-office teams. Following the acquisition, additional coverage focuses on how Enfusion’s technology is being used within Clearwater’s platform to support institutional investors.
Investors and researchers can use this ENFN news feed as an archive of transaction announcements, earnings-related disclosures, and strategic updates involving Enfusion, both as an independent public company and as part of Clearwater Analytics.
Enfusion (NYSE: ENFN) has announced the appointment of Bronwen Bastone as Chief People Officer and the election of Jan Hauser and Kathleen DeRose to its Board of Directors. Bastone brings over 20 years of experience in human capital management, previously holding senior roles at major financial institutions. DeRose and Hauser will enhance the board's expertise in financial services and fintech. CEO Thomas Kim expressed confidence in the new appointments as Enfusion aims to strengthen its leadership and client service capabilities.
Enfusion, a cloud-based investment management software provider, reported a strong third quarter for 2021 with revenue increasing 46.8% year over year to $29.0 million. Key drivers included new client signings and growth from existing clients, with Platform Subscriptions revenue growing 48.4% to $27.1 million. However, income from operations fell to $4.9 million, down from $6.2 million in the prior year, and net income decreased to $3.3 million from $5.6 million. Looking ahead, Enfusion anticipates fourth-quarter revenue between $30.0 and $30.5 million.
Plate IQ has secured $160 million in Series B funding led by FTV Capital to enhance its AP automation solutions. Under new CEO Barrett Boston, the company aims to expand its VendorPay network across diverse industries. Since March 2020, Plate IQ has onboarded over 8,000 customers and processed more than $2 billion in payments. The platform, noted for its significant impact on the restaurant sector, processes over 50,000 invoices daily, emphasizing its growth potential in the evolving digital payments landscape.
Vagaro, a cloud-based business management platform for health and wellness industries, has raised new funding led by FTV Capital, valuing the company at $1 billion. The investment will enhance Vagaro's tools for appointment booking, inventory management, and payroll, supporting international growth in location value="LC/ca"Canada, location value="LC/au"Australia, and the location value="LC/gb"United Kingdom. The company reported a 105% increase in client sales over the past year and aims to capture a share of the $10.5 billion health and wellness market.
Enfusion, a provider of cloud-based investment management solutions, successfully closed its IPO, offering 21,562,500 shares of Class A stock priced at $17.00 per share. This includes the full exercise of underwriters' options to purchase an additional 2,812,500 shares. The offering consisted of 16,839,107 shares sold by Enfusion and 4,723,393 shares by existing stockholders. The IPO proceeds will be utilized to acquire equity interests in its subsidiary and for debt repayment, IPO expenses, and corporate needs. Shares began trading on the NYSE on October 21, 2021 under the symbol ENFN.
Enfusion, a provider of cloud-based investment management software, has priced its initial public offering (IPO) at $17.00 per share. The offering includes 15,322,660 shares from the company and 3,427,340 shares from existing stockholders, totaling 18,750,000 shares. An additional 2,812,500 shares may be purchased by underwriters within 30 days. Trading starts on October 21, 2021, with closing expected on October 25, 2021. Net proceeds will fund equity purchases in its subsidiary and repay debt.